Obama gives powerful drug lobby a seat at healthcare table
Drug companies—the leading source of lobbyist money—now have "a seat at the table" at the White House and on Capitol Hill as healthcare legislation works its way through Congress. The pharmaceutical industry's political transformation provides an example of Obama's approach to achieving his healthcare goals, which includes negotiation and compromise, even with those that the administration previously portrayed as a source of the problem.
- Senators Hear How Two-Midnight Rule Harms Patients, Hospitals
- 3 Management Lessons from a Supermarket Debacle
- Medicare Advantage Carriers See 'No Choice' But to Accept Cuts
- Physicians to Appeal 'Docs v. Glocks' Ruling in FL
- IOM Identifies GME Problems, Calls for Finance Changes
- Healthcare Costs Start With What We Eat
- Revenue Cycles Get a Boost from Simple JPEG Files
- Handshaking Spreads Germs. Get Over It.
- Hospitals Likely to Outsource ICD-10 at Launch
- CA Fines 8 Hospitals for Medical Errors